DRKS00034230尚未招募Unknown
Cognitive training for patients with schizophrenia in forensic psychiatry: a pilot study
VR-Klinikum Düsseldorf0 个研究点目标入组 15 人开始时间: 2024年6月10日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 30 Years 至 one(—)
- 性别
- Male
入选标准
- •Patients who are forensically accommodated or
- •- patients of the forensic aftercare outpatient clinic
- •- both patients capable of giving consent and patients not capable of giving consent (for the latter, the consent of the legal guardian is also obtained)
- •- Main diagnosis F20
- •- Male gender
- •- Age: 30 years and older
- •- Native speaker of German or sufficient language skills to actively participate in the cognitive training program and the neuropsychological examinations
排除标准
- •Physical disabilities or illnesses that prevent participation in the study (e.g. bedriddenness, blindness, deafness)
研究者
相似试验
招募中
不适用
Cognitive training for schizophrenia: a randomized controlled trialSchizophreniaJPRN-UMIN000039521Shinshu University86
已完成
不适用
Cognitive Training for Patients With SchizophreniaOther Primary Psychotic DisordersSchizophreniaSchizoaffective DisorderNCT01521026University of California, San Diego69
进行中(未招募)
1 期
Pharmakotherapie kognitiver Defizite bei schizophrenen Störungen – Randomisierte placebokontrollierte Doppelblindstudie mit Pergolid versus TolcaponTOCTAP (Treatment of Cognitive Deficits in Schizophrenia with Tolcapone and Pergolide) - TOCTAPDas vorliegende Projektvorhaben dient der Untersuchung, inwieweit bei Patienten mit schizophrenen Störungen neben einer bestehenden Monotherapie mit Paliperidon (Invega), dem zuletzt zugelassenen neuartigen Antipsychotikum der sog. zweiten Generation, eine additive prodopaminerge Psychopharmakotherapie mit Tolcapon (Tasmar) oder Pergolid (Parkotil) die präfrontalen kognitiven Funktionen beeinflusst.EUCTR2008-006905-18-DERWTH Aachen University60
已完成
不适用
Treatment Of Cognitive deficits in schizophrenia with Tolcapone And PergolideSchizophreniaISRCTN42412532RWTH Aachen University (Germany)60
已完成
不适用
Cognitive Remediation of Schizophrenia in a Community Mental Health SettingExperimental Condition TCTControlled Condition CGNCT01988714University of California, San Francisco112
